Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flow from operating activities:
Net loss	$ (1,836,642)	$ (126,723)	$ (119,857)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	29,076	13,864	10,755
Stock-based compensation	1,606,020	476	771
Non-cash equity consideration	(24,185)	0	0
Loss on equity method investments	77,284	396	27,533
Loss on investments	11,543	3,733	27,200
Change in fair value of loans receivable	3,508	(1,061)	(914)
Change in fair value of warrant liabilities	(58,615)	0	0
Other non-cash activity	(270)	0	(728)
Changes in operating assets and liabilities:
Accounts receivable ($614 , ($995) and ($2,221) from related parties)	(114,094)	(14,228)	(1,843)
Prepaid expenses and other current assets	(2,981)	(11,352)	(4,031)
Inventory, net	(626)	(2,736)
Other non-current assets	(539)	1,834	(2,361)
Accounts payable	(2,247)	7,019	664
Accrued expenses and other current liabilities	44,796	8,665	4,170
Deferred revenue, current and non-current ($40,743, ($22,253) and $3,112 from related parties)	(10,498)	(19,423)	4,883
Deferred rent, non-current	6,032	1,045	9,095
Other non-current liabilities	18,620	2,661
Net cash used in operating activities	(253,818)	(135,830)	(44,663)
Cash flow from investing activities:
Purchases of property and equipment	(56,521)	(57,821)	(22,219)
Purchases and issuances of loan receivable		(10,100)	(2,250)
Proceeds from loans receivable	304	800
Purchase of non-marketable equity securities	(5,000)		(50,133)
Business acquisition, net of cash acquired	(12,040)
Net cash used in investing activities	(73,257)	(67,121)	(74,602)
Cash flow from financing activities:
Proceeds from reverse recapitalization, net of redemptions of $867,253 and offering costs of $106,838 (Note 3)	1,509,629
Proceeds from exercise of stock options	167	26	7
Repurchase of Founder shares	(24,998)		(408)
Taxes paid related to net share settlement of restricted stock units	(9,463)
Principal Payments On Capital Leases And Lease Financing Obligation	(1,123)	(748)	(828)
Proceeds from lease financing obligation	0	0	476
Contributions from non-controlling interests	59,933	0	0
Proceeds from issuance of convertible promissory notes, net of issuance costs	0	0	198,957
Proceeds from issuance of Series E convertible preferred stock, net of issuance costs	0	91,040	212,181
Net cash provided by financing activities	1,534,145	90,318	410,385
Effect of foreign exchange rates on cash and cash equivalents	(19)
Net increase (decrease) in cash, cash equivalents and restricted cash	1,207,051	(112,633)	291,120
Cash, cash equivalents and restricted cash, beginning of period	385,877	498,510	207,390
Cash, cash equivalents and restricted cash, end of period	1,592,928	385,877	498,510
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	2,370	2,572	2,348
Cash paid for income taxes	61		31
Supplemental disclosure of non-cash investing and financing activities:
Purchases of equipment through capital leases	1,981		406
Purchases of property and equipment included in accounts payable and accrued expenses	1,815	14,458	605
Equity received in related parties	61,554		24,480
Purchase Of Non Cash Marketable Equity Securities	10,000
Issuance of common stock for a business acquisition	15,087
Acquisition date fair value of contingent consideration	(8,760)
Purchases and issuances of loans receivable		375	2,744
Initial fair value of warrant liabilities	194,453
Conversion of convertible promissory notes to preferred stock	195		211,608
Series E convertible preferred stock issuance costs included in accrued expenses			3,380
Lease financing obligation for build-to-suit lease	6,120
Restricted Cash	42,924	5,076	3,223
Cash and cash equivalents	1,550,004	380,801	495,287
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total	$ 1,592,928	$ 385,877	$ 498,510